Showing results (1041-1050 of 6,768) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|August 22, 2018
Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General PracticeJean Ferrières, Katherine Gorcyca, Şerban R Iorga, et al.Clinical Therapeutics|August 27, 2018
Health Care Resource Utilization and Costs Associated with Transitioning to 3-month Paliperidone Palmitate Among US VeteransMaral DerSarkissian, Patrick Lefebvre, Kruti Joshi, et al.Clinical Therapeutics|May 22, 2017
Systemic Treatment Patterns With Advanced or Recurrent Non-small Cell Lung Cancer in Japan: A Retrospective Hospital Administrative Database StudyFeng Wang, Sari Mishina, Shinji Takai, et al.Clinical Therapeutics|May 28, 2018
Effects of Nemonoxacin on Thorough ECG QT/QTc Interval: A Randomized, Placebo- and Positive-controlled Crossover Study in Healthy Chinese AdultsCaiyun Zhao, Yuan Lv, Xiangyan Li, et al.Clinical Therapeutics|May 9, 2018
Utilization Patterns of Lipid-lowering Therapies in Patients With Atherosclerotic Cardiovascular Disease or Diabetes: A Population-based Study in South KoreaSiin Kim, Hyungtae Kim, Eunju Kim, et al.Clinical Therapeutics|April 17, 2018
Legacy Effect of Intensive Blood Glucose Control on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Very High Risk or Secondary Prevention of Cardiovascular Disease: A Meta-analysis of Randomized Controlled TrialsXinyue Zhang, Yuqi Liu, Fang Zhang, et al.Clinical Therapeutics|May 16, 2019
Clinical and Demographic Parameters of Patients Treated Using a Sepsis ProtocolHillary H Ward, Emily A Kiernan, Christine L Deschler, et al.Clinical Therapeutics|May 20, 2019
The Economic Burden of Congenital Cytomegalovirus Disease in the First Year of Life: A Retrospective Analysis of Health Insurance Claims Data in the United StatesJuliana Meyers, Anushua Sinha, Salome Samant, et al.Clinical Therapeutics|May 13, 2019
Monitoring Drug Safety in Rheumatoid Arthritis Prevention TrialsMartha R Neagu, Michael A Weinreich, Thao T Doan, et al.Clinical Therapeutics|May 1, 2019
Comparative Cost-utility Analysis Between Aprepitant- and Fosaprepitant-containing Regimens To Prevent Chemotherapy-induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy in JapanMunenobu Kashiwa, Ryo MatsushitaPageof 677